Yuri Maricich
CIK 1881045 · Chief Medical Officer · last filed 2026-08-05
Yuri Maricich is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $10.8K of CAMP on Aug 5, 2026. Across all open-market trades the lifetime net is +$7.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $58.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$58.6K
2
10
$7.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAMP | Chief Medical Officer | 12,611 | $4.65 | $58.6K | $20.8K | 5 | 2026-08-05 |
| Pear Therapeutics, Inc. (PEARW) Delisted | Chief Medical Officer | 94,333 | $0.01 | $557 | -$13.7K | 5 | 2023-02-17 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-05 | CAMP | Buy (P) | +6,551 | $10.8K | EDGAR |
| 2026-04-03 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2025-12-22 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2025-09-11 | CAMP | Buy (P) | +6,060 | $10.0K | EDGAR |
| 2025-04-03 | CAMP | Grant (A) | — | $0 | EDGAR |
| 2023-02-17 | Pear Therapeutics, Inc. (PEARW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-24 | Pear Therapeutics, Inc. (PEARW) Delisted | Sell (S) | −12,162 | -$13.7K | EDGAR |
| 2023-01-18 | Pear Therapeutics, Inc. (PEARW) Delisted | Exer (M) | +30,800 | $0 | EDGAR |
| 2022-02-18 | Pear Therapeutics, Inc. (PEARW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-07 | Pear Therapeutics, Inc. (PEARW) Delisted | Grant (A) | +73,620 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.